Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial

BACKGROUND: The optimal anticoagulation strategy for patients with atrial fibrillation (AF) and bioprosthetic valve (BPV) replacement or native valve repair remains uncertain. HYPOTHESIS: We evaluated the safety and efficacy of apixaban vs warfarin in patients with AF and a history of BPV replacemen...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Cardiol
Main Authors: Guimarães, Patricia O., Pokorney, Sean D., Lopes, Renato D., Wojdyla, Daniel M., Gersh, Bernard J., Giczewska, Anna, Carnicelli, Anthony, Lewis, Basil S., Hanna, Michael, Wallentin, Lars, Vinereanu, Dragos, Alexander, John H., Granger, Christopher B.
Formato: Artigo
Idioma:Inglês
Publicado: Wiley Periodicals, Inc. 2019
Assuntos:
Clinical Investigations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6522998/
https://ncbi.nlm.nih.gov/pubmed/30907005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23178
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares